Erlotinib

Drug Details

Erlotinib, known by the brand name Tarceva, is an oral medication prescribed for treating certain types of lung and pancreatic cancers. Specifically, it is used for metastatic non-small cell lung cancer (NSCLC) in some adults and for advanced, unresectable, or metastatic pancreatic cancer, often in combination with another drug called gemcitabine (Gemzar). Erlotinib functions as a targeted anticancer treatment by inhibiting a specific protein called the epidermal growth factor receptor (EGFR), which is present in higher amounts on cancer cells compared to healthy cells. By blocking EGFR, erlotinib helps to slow or stop the growth and spread of cancer cells. Patients should be aware that while erlotinib is an effective treatment option, it may cause side effects such as skin rashes and diarrhea. It is important to consult with healthcare professionals before starting treatment to ensure it is safe and appropriate for individual health needs.